“…Atypical respiratory pathogens, for example Mycoplasma pneumoniae, Legionella species, and Chlamydia pneumoniae, are isolated with increasing frequency from CAP, and the incidence of dual bacterial infections varies from 2 to 14% [24]. Because clinical differentiation of typical, atypical, and viral pneumonia in children remains challenging [25,26], appropriate empiric antibiotic therapy is still the mainstay of treatment for children with CAP. Nevertheless, no role of treatment with macrolides could be shown as an effective factor on prognosis in this study.…”